A phase III randomized, double-blind, double-dummy, multi-center study to compare the efficacy, safety, and tolerability of tolterodine extended release capsule with tolterodine immediate release tablet in subjects with symptoms of overactive bladder.

Trial Profile

A phase III randomized, double-blind, double-dummy, multi-center study to compare the efficacy, safety, and tolerability of tolterodine extended release capsule with tolterodine immediate release tablet in subjects with symptoms of overactive bladder.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 29 Dec 2009 Actual end date (October 2006) added as reported by ClinicalTrials.gov.
    • 29 Dec 2009 Actual patient number (260) added as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top